Cambridge Investment Research Advisors’s Rockwell Medical RMTI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$7K	–	3256
2021 Q3	$7K	Hold	100	–	–	﹤0.01%	3082
2021 Q2	$10K	Buy	+100	New	+$10.3K	﹤0.01%	3076
2021 Q1	–	Sell	-94	Closed	-$10K	–	2972
2020 Q4	$10K	Buy	+94	New	+$10.5K	﹤0.01%	2699
2019 Q4	–	Sell	-105	Closed	-$32K	–	2464
2019 Q3	$32K	Hold	105	–	–	﹤0.01%	2304
2019 Q2	$35K	Hold	105	–	–	﹤0.01%	2164
2019 Q1	$66K	Sell	105 -2	-2%	-$912	﹤0.01%	2214
2018 Q4	$27K	Buy	+107	New	+$42.6K	﹤0.01%	2110
2014 Q2	–	Sell	-398	Closed	-$554K	–	1369
2014 Q1	$554K	Buy	+398	New	+$518K	0.02%	670

Other funds holding RMTI

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cambridge Investment Research Advisors's RMTI Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of Rockwell Medical (RMTI) in Q4 2021, closing a stake of 100 shares — an estimated $7K sold.

Cambridge Investment Research Advisors first reported a position in RMTI in Q1 2014 and held it in 8 quarters. The position peaked at $554K in Q1 2014. 62 funds tracked by Wall St. Rank hold RMTI as of Q4 2021.

Cambridge Investment Research Advisors reported no remaining Rockwell Medical position as of Q4 2021 after selling out during the quarter.
Cambridge Investment Research Advisors sold 100 Rockwell Medical shares in Q4 2021, an estimated $7K.
Cambridge Investment Research Advisors first reported a position in Rockwell Medical in Q1 2014 and held it in 8 quarters.
Cambridge Investment Research Advisors's Rockwell Medical position peaked at $554K in Q1 2014.
62 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.